Patients With Non Small Cell Lung Cancer clinical trials

Explore recruiting patients with non small cell lung cancer clinical trials.

Recruiting patients with non small cell lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Non Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Repurposing statins as adjuvants for cancer patients receiving therapy with immune checkpoint inhibitors: the STARK trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

BEVERLY: A randomized open-label phase 3 trial comparing bevacizumab + erlotinib vs erlotinib alone as first line treatment of patients with EGFR mutated advanced non squamous non small cell lung cancer

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase I clinical trial evaluating TG4070 in patients with non-small cell lung cancer

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A phase II study to evaluate the imaging potential of 68GaNOTA-Anti-MMR VHH2 for in vivo imaging of MMR-expressing Macrophages by means of Positron Emission Tomography (PET) in patients with non-small cell lung cancer (NSCLC).

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

The Expression of Fibroblast Activation Protein in Patients with Non-Small Cell Lung Cancer Patients

Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase I clinical trial of TG4050 combined with nivolumab in patients with Non-Small Cell Lung Cancer.

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Patients With Non Small Cell Lung Cancer trials by city

Patients With Non Small Cell Lung Cancer in Toronto Patients With Non Small Cell Lung Cancer in Vancouver Patients With Non Small Cell Lung Cancer in Montreal Patients With Non Small Cell Lung Cancer in Calgary Patients With Non Small Cell Lung Cancer in Edmonton Patients With Non Small Cell Lung Cancer in Ottawa Patients With Non Small Cell Lung Cancer in Winnipeg Patients With Non Small Cell Lung Cancer in Quebec City Patients With Non Small Cell Lung Cancer in Hamilton Patients With Non Small Cell Lung Cancer in Kitchener Patients With Non Small Cell Lung Cancer in London Patients With Non Small Cell Lung Cancer in Halifax Patients With Non Small Cell Lung Cancer in New York Patients With Non Small Cell Lung Cancer in Los Angeles Patients With Non Small Cell Lung Cancer in Chicago Patients With Non Small Cell Lung Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease